John J Mariani

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Alcohol Use Disorder

Stem Cell Transplantation

Top Venues

The American journal on addictions

Experimental and clinical psychopharmacology

Alcoholism, clinical and experimental research

Columbia University Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Columbia University Medical Center

United States

Associate Professor :: Psychiatry

New York State Psychiatric Institute

United States

Director, Substance Treatment and Research Service :: Substance Use Disorders

Publications

Kenneth M Carpenter, C Jean Choi, Cale Basaraba, Martina Pavlicova, Daniel J Brooks, Christina A Brezing, Adam Bisaga, Edward V Nunes, John J Mariani, Frances R Levin
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial. Experimental and clinical psychopharmacology (2023)
John J Mariani, Robert L Dobbins, Amy Heath, Frank Gray, Howard Hassman
Open-label investigation of rapid initiation of extended-release buprenorphine in patients using fentanyl and fentanyl analogs. The American journal on addictions (2023)
John J Mariani, Amy L Mahony, Samuel C Podell, Daniel J Brooks, Christina Brezing, Sean X Luo, Nasir H Naqvi, Frances R Levin
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanyl. The American journal on addictions 30 (5) (2021)
John J Mariani, Martina Pavlicova, Cale Basaraba, Agnieszka Mamczur-Fuller, Daniel J Brooks, Adam Bisaga, Kenneth M Carpenter, Edward V Nunes, Frances R Levin
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorder. Alcoholism, clinical and experimental research 45 (8) (2021)
John J Mariani, Amy Mahony, Muhammad N Iqbal, Sean X Luo, Nasir H Naqvi, Frances R Levin
Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users. The American journal on addictions 29 (4) (2020)